Experiment: 2HM8

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	1mM unlabelled 13C Pdcd4 MA-3C; 100mM NaCl, 25mM NAH2PO4, 0.5mM DTT, 10uM EDTA, pH6.5	100% D20	150mM	6.5	ambient	298
2	2D TOCSY	1mM unlabelled 13C Pdcd4 MA-3C; 100mM NaCl, 25mM NAH2PO4, 0.5mM DTT, 10uM EDTA, pH6.5	100% D20	150mM	6.5	ambient	298
3	3D_13C-separated_NOESY	1mM U-13C (unlabelled aromatics) Pdcd4 MA-3C; 100mM NaCl, 25mM NAH2PO4, 0.5mM DTT, 10uM EDTA, pH6.5	100% D20	150mM	6.5	ambient	298
4	3D_15N-separated_NOESY	0.6mM U-15N Pdcd4 MA-3C; 100mM NaCl, 25mM NAH2PO4, 0.5mM DTT, 10uM EDTA, pH6.5	10% D20, 90% H20	150mM	6.5	ambient	298
5	3D HCCH-TOCSY	1mM U-13C (unlabelled aromatics) Pdcd4 MA-3C; 100mM NaCl, 25mM NAH2PO4, 0.5mM DTT, 10uM EDTA, pH6.5	100% D20	150mM	6.5	ambient	298
6	3D_15N TOCSY	0.6mM U-15N Pdcd4 MA-3C; 100mM NaCl, 25mM NAH2PO4, 0.5mM DTT, 10uM EDTA, pH6.5	10% D20, 90% H20	150mM	6.5	ambient	298
7	3D HNCACB	0.7mM U-15N, 13C Pdcd4 MA-3C; 100mM NaCl, 25mM NAH2PO4, 0.5mM DTT, 10uM EDTA, pH6.5	10% D20, 90% H20	150mM	6.5	ambient	298
8	3D CBCA(CO)NH	0.7mM U-15N, 13C Pdcd4 MA-3C; 100mM NaCl, 25mM NAH2PO4, 0.5mM DTT, 10uM EDTA, pH6.5	10% D20, 90% H20	150mM	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	DRX	600
3	Varian	INOVA	800

NMR Refinement
Method	Details	Software
simulated annealing		VNMR

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	49
Representative Model	33 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VNMR	5.3	varian
2	collection	TopSpin	1.2	bruker
3	processing	NMRPipe	97.027.12.56	Delaglio
4	processing	TopSpin	1.2	bruker
5	data analysis	Sparky	3	T. D. Goddard and D. G. Kneller
6	structure solution	CYANA	2.1	Guentert
7	refinement	CYANA	2.1	Guentert

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.